Results 241 to 250 of about 129,945 (312)

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

ITCH regulates Golgi integrity and proteotoxicity in neurodegeneration. [PDF]

open access: yesSci Adv
Xiang Q   +10 more
europepmc   +1 more source

[Systemic sclerosis : A disease with multiple faces]. [PDF]

open access: yesDermatologie (Heidelb)
Evers C, Distler J, Distler O.
europepmc   +1 more source

The Molecular Architecture of Neurodegeneration: An Integrative Overview of Convergent Mechanisms. [PDF]

open access: yesNeuroSci
Aranda-Abreu GE   +5 more
europepmc   +1 more source

Interactome screening implicates BAG6 as a suppressor of UBQLN2 misfolding in ALS/FTD. [PDF]

open access: yesFront Mol Neurosci
Kim SH   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy